Commission Implementing Regulation (EU) 2023/2215 of 23 October 2023 authorising the placing on the market of 6′-Sialyllactose sodium salt produced by derivative strain of Escherichia coli W (ATCC 9637) as a novel food and amending Implementing Regulation (EU) 2017/2470
Articolo 2
In vigore · versione del 13 nov 2023
Only the company Kyowa Hakko Bio Co., Ltd ( 19 ) is authorised to place on the market within the Union the novel food referred to in Article 1, for a period of five years from 13 November 2023, unless a subsequent applicant obtains an authorisation for that novel food without reference to the scientific data protected pursuant to Article 3 or with the agreement of Kyowa Hakko Bio Co., Ltd.